Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Marco Valgimigli
,
Vijay Kunadian
,
Pascal Vranckx
,
et al
Start date:
Feb 22, 2023
View more
Author(s):
Marco Valgimigli
,
Eliano Navarese
,
Pascal Vranckx
Added:
1 year ago
This three-part programme delves into the critical importance of individualised antithrombotic treatment in both Acute Coronary Syndrome (ACS) and Chronic Coronary Syndrome (CCS).
Part one of this programme presents two compelling patient case studies.Prof Pascal Vranckx (Hartcentrum Hasselt, BE) presents a complex 62-year old male with stable angina and HFrEF, undergoing an elective…
View more
Coronary Artery Disease in SMI
Author(s):
Brian Tam To
,
Roman Roy
,
Narbeh Melikian
,
et al
Added:
10 months ago
Article
Author(s):
Jonathon A Leipsic
,
Jonathan Weir-McCall
,
Philipp Blanke
Added:
3 years ago
Coronary CTA has rapidly gone from a test with potential to be considered a first-line test for patients with stable chest pain.1 It provides robust ability to exclude atherosclerosis and coronary artery stenosis and more recently has been shown to inform and guide clinical treatment making in a fashion that enables a reduction in myocardial infarction when compared to traditional stress testing…
View more
CAD in Patients Undergoing TAVI
Author(s):
Yinghao Lim
,
Kent Anthony Tan
,
Ivandito Kuntjoro
,
et al
Added:
1 year ago
Article
Author(s):
Anouar Belkacemi
,
Pierfrancesco Agostoni
,
Michiel Voskuil
,
et al
Added:
3 years ago
In the past few decades, major progress has been made in the percutaneous treatment of coronary artery disease. Initially, the emergence of balloon angioplasty offered an alternative option for coronary revascularisation. However, abrupt closure and restenosis caused by elastic recoil, neointimal hyperplasia and late remodelling were major drawbacks of balloon angioplasty.1 The use of drug…
View more
Author(s):
Raffaele De Caterina
,
Carlo De Innocentiis
,
Marco Zimarino
Added:
3 years ago
Multivessel coronary artery disease (MVCAD) is defined by the presence of ≥50% diameter stenosis of two or more epicardial coronary arteries. The presence of MVCAD indicates poorer prognosis and a significantly higher mortality than single-vessel disease. In MVCAD, revascularisation can be achieved by either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).1,2 A…
View more
Treatment of Bifurcation Coronary Artery Disease with the Dedicated Cappella Sideguard® Stent
Author(s):
Mamas A Mamas
,
Farzin Fath-Ordoubadi
Added:
3 years ago
Article